Target Hemoglobin May Be Achieved with Intravenous Iron Alone in Anemic Patients with Cardiorenal Syndrome: An Observational Study

Conclusion: Our observational study suggests that IV iron treatment without ESAs may substantially raise the Hb level to ≥11 g/dl in CRS patients. This treatment strategy may reduce the use of ESAs and hence its potential adverse effects.Cardiorenal Med 2015;5:246-253

http://www.karger.com/Article/FullText/433564

Source: Cardiorenal Medicine - July 4, 2015 Category: Urology & Nephrology Source Type: research